An international survey of current management practices for polymyalgia rheumatica by general practitioners and rheumatologists
- 13 January 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 62 (8) , 2797-2805
Abstract
Objectives: To explore current management practices for PMR by general practitioners (GPs) and rheumatologists including implications for clinical trial recruitment. Methods: An English language questionnaire was constructed by a working group of rheumatologists and GPs from six countries. The questionnaire focused on: 1: Respondent characteristics; 2: Referral practices; 3: Treatment with glucocorticoids; 4: Diagnostics; 5: Comorbidities; and 6: Barriers to research. The questionnaire was distributed to rheumatologists and GPs worldwide via members of the International PMR/Giant Cell Arteritis Study Group. Results: In total, 394 GPs and 937 rheumatologists responded to the survey. GPs referred a median of 25% of their suspected PMR patients for diagnosis and 50% of these were returned to their GP for management. In general, 39% of rheumatologists evaluated patients with suspected PMR >2 weeks after referral, and a median of 50% of patients had started prednisolone before rheumatologist evaluation. Direct comparison of initial treatment showed that the percentage prescribing >25 mg prednisolone daily for patients was 30% for GPs and 12% for rheumatologists. Diagnostic imaging was rarely used. More than half (56%) of rheumatologists experienced difficulties recruiting people with PMR to clinical trials. Conclusion: This large international survey indicates that a large proportion of people with PMR are not referred for diagnosis, and that the proportion of treatment-naive patients declined with increasing time from referral to assessment. Strategies are needed to change referral and management of people with PMR, to improve clinical practice and facilitate recruitment to clinical trials.Keywords
Funding Information
- AbbVie
- Swiss Foundation for Research on Muscle Diseases
- Aarhus University Hospital and Central Denmark Region
This publication has 28 references indexed in Scilit:
- Is cancer associated with polymyalgia rheumatica? A cohort study in the General Practice Research DatabaseAnnals of the Rheumatic Diseases, 2014
- Polymyalgia rheumatica: diagnosis, prescribing, and monitoring in general practiceBritish Journal of General Practice, 2013
- 2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiativeAnnals of the Rheumatic Diseases, 2012
- Cancer risk in patients hospitalized with polymyalgia rheumatica and giant cell arteritis: a follow-up study in SwedenRheumatology, 2010
- A Survey Of Primary Care Physicians In Eleven Countries, 2009: Perspectives On Care, Costs, And ExperiencesHealth Affairs, 2009
- Polymyalgia rheumatica in primary care: a cohort study of the diagnostic criteria and outcomeFamily Practice, 2008
- Use of physician services in a population-based cohort of patients with polymyalgia rheumatica over the course of their diseaseArthritis & Rheumatism, 2005
- Impact of national health care systems on patient evaluations of general practice in EuropeHealth Policy, 2004
- Presenting features of polymyalgia rheumatica (PMR) and rheumatoid arthritis with PMR-like onset: a prospective studyAnnals of the Rheumatic Diseases, 2001
- A DISTRICT AUDIT ON THE MANAGEMENT OF POLYMYALGIA RHEUMATICA AND GIANT CELL ARTERITISRheumatology, 1994